Perry W. Guinn, Gary N. Mills, Robert A. Bedient and Martin O. Greeley v. Henry B. Kopf

96 F.3d 1419
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 12, 1996
Docket96-1098
StatusPublished
Cited by24 cases

This text of 96 F.3d 1419 (Perry W. Guinn, Gary N. Mills, Robert A. Bedient and Martin O. Greeley v. Henry B. Kopf) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Perry W. Guinn, Gary N. Mills, Robert A. Bedient and Martin O. Greeley v. Henry B. Kopf, 96 F.3d 1419 (Fed. Cir. 1996).

Opinion

RICH, Circuit Judge.

Perry W. Guinn, Gary N. Mills, Robert A Bedient, and Martin 0. Greeley (collectively Guinn) appeal the judgment of the Board of Patent Appeals and Interferences (Board) mailed on November 29, 1994 in Patent Interference No. 103,096, wherein the sole count in issue in the interference was awarded to appellee Kopf, and the Board held that Kopf was entitled to a patent containing claims 19-31 in application Serial No. 07/442,- *1420 240, and a patent containing claims 20-38 in application Serial No. 07/207,655, with the proviso that Kopf avoid a double patenting rejection upon resumption of prosecution upon termination of the interference. 1 We have jurisdiction under 28 U.S.C. § 1295(a)(4)(A) (1994) and 35 U.S.C. § 141 (1994) to review this appeal from the final decision of the Board. We affirm.

Background

On September 29, 1994, Interference No. 103,096 was redeelared by the United States Patent and Trademark Office (PTO) between United States Patent No. 4,889,812 (’812 patent) issued to Guinn and two patent applications of Kopf with Serial Nos. 07/442,240 (’240 patent application) and 07/207,655 (’655 patent application). The redeelared interference contained a single count corresponding to claim 9 of the ’812 patent, claims 19-31 of the ’240 patent application, and claims 20-38 of the ’655 patent application.

On October 13, 1994, Guinn attempted to terminate the interference by filing a statutory disclaimer under 35 U.S.C. § 253 of claim 9, the only claim of the ’812 patent corresponding to the single count of the interference, and a concurrent motion pursuant to 37 C.F.R. § 1.635 to dismiss the interference for lack of jurisdiction. Guinn asserted that as a result of the disclaimer of claim 9, no claim which corresponded to the single count of the interference remained in the ’812 patent so that no controversy existed between the parties. Therefore, Guinn reasoned that the Board had no jurisdiction to enter a judgment and should have dismissed the interference. To this end, Guinn specifically stated in the statutory disclaimer that: “This disclaimer is not a request for entry of an adverse judgment under 37 C.F.R. § 1.662.”

In response to the motion to dismiss filed by Guinn, on November 1, 1994 the Board issued an order to show cause why judgment should not be entered against Guinn as a result of the statutory disclaimer. The Board stated that even though Guinn specifically asserted in his statutory disclaimer that it was not a request for entry of an adverse judgment, “[pjursuant to 37 CFR 1.662(c), the statutory disclaimer will be treated as a request for entry of an adverse judgment against Guinn et al.”

Guinn filed a response to the order to show cause reasserting the argument that 37 C.F.R. § 1.662(c) was invalid as a matter of law because the Board lacked jurisdiction to enter judgment against Guinn because Guinn was no longer “claiming the same patentable invention” as required by 35 U.S.C. § 135(a) with the advent of the disclaimer of claim 9 of the ’812 patent. On November 14, 1994, Kopf filed a response to Guinn’s response to the order to show cause asserting that the Commissioner had the authority under the broad jurisdiction over patent matters granted to him by Congress in 35 U.S.C. § 6 to promulgate 37 C.F.R. § 1.662(c). Kopf argued that by disclaiming under 35 U.S.C. § 253 the only claim involved in the interference, Guinn conceded that the invention was unpatentable to him and that adverse judgment was appropriate as called for by 37 C.F.R. § 1.662(c).

The Board issued its final decision on November 29, 1994 entering a judgment as to the sole count in issue in the interference to appellee Kopf, and awarding a patent containing claims 19-31 of the ’240 patent application to Kopf, and a patent containing claims 20-38 of the ’655 patent application to Kopf, with the proviso that Kopf avoid the double patenting rejection upon resumption of prosecution upon termination of the interference.

On December 9, 1994, Guinn filed a petition pursuant to 37 C.F.R. § 1.644(a)(1) and (2) requesting that the judgment of the Board be vacated, that 37 C.F.R. § 1.662(e) be declared invalid and void because it is “inconsistent with law” and exceeds the power vested in the Commissioner under 35 U.S.C. §§ 6 and 7, and that the judgment be vacated because at the time it was entered, no actual controversy existed between the *1421 parties and the Board had no jurisdiction. Kopf responded by arguing again that the Commissioner properly promulgated 37 C.F.R. § 1.662(c) under 35 U.S.C. §§ 6 and 7 providing the Board with valid jurisdiction to enter adverse judgment against Guinn in the interference. On January 23,1995 the Board denied the petition ruling that 37 C.F.R. § 1.662(c) is not inconsistent with 35 U.S.C. § 253 and was within the scope of the Commissioner’s authority to establish regulations for the conduct of proceedings within the PTO under 35 U.S.C. § 6.

Discussion

The single issue we must decide is whether the Commissioner properly promulgated 37 C.F.R. § 1.662(c) (Rule 1.662(e)) under the authority granted by Congress under 35 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sipco, LLC v. Emerson Electric Co.
939 F.3d 1301 (Federal Circuit, 2019)
Velocity Patent LLC v. FCA US LLC
319 F. Supp. 3d 950 (E.D. Illinois, 2018)
Apotex, Inc. v. Daiichi Sankyo, Inc.
781 F.3d 1356 (Federal Circuit, 2015)
Japanese Foundation for Cancer Research v. Lee
773 F.3d 1300 (Federal Circuit, 2014)
In Re Yamazaki
702 F.3d 1327 (Federal Circuit, 2012)
Abbott GmbH & Co. v. Centocor Ortho Biotech, Inc.
870 F. Supp. 2d 206 (D. Massachusetts, 2012)
Teva Pharmaceuticals USA, Inc. v. Eisai Co., Ltd.
620 F.3d 1341 (Federal Circuit, 2010)
3V, INC. v. CIBA Specialty Chemicals Corp.
587 F. Supp. 2d 641 (D. Delaware, 2008)
White Mule Co. v. ATC LEASING CO. LLC
540 F. Supp. 2d 869 (N.D. Ohio, 2008)
McMullin v. Carroll
153 F. App'x 738 (Federal Circuit, 2005)
In Re Robert J. Gartside and Richard C. Norton
203 F.3d 1305 (Federal Circuit, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
96 F.3d 1419, Counsel Stack Legal Research, https://law.counselstack.com/opinion/perry-w-guinn-gary-n-mills-robert-a-bedient-and-martin-o-greeley-v-cafc-1996.